Frequency of Blood Eosinophilia in newly diagnosed Chronic Obstructive Pulmonary Disease patients

Abstract

Objective: To determine Blood Eosinophilia frequency in newly diagnosed Chronic Obstructive Pulmonary Disease patients.
 Methods: An observational cross-sectional research on newly diagnosed COPD patients with age ≥ 40 years was performed at Ojha Institute of Chest Diseases, Dow University of Health Sciences Karachi. COPD patients diagnosed in outpatient clinic or admitted in Chest Unit during six-month period from September 2018 to May 2019 were selected. Each patient underwent spirometry, and blood was tested for eosinophilia (≥ 2% eosinophils in blood), after obtaining informed consent and clinical history.
 Results: One hundred and fifty COPD patients were diagnosed and evaluated for Blood Eosinophilia, out of which 86 (57.3%) and 64 (42.7%) patients were Males and Females respectively with mean age of 63.72 ± 10.24 years. Current Smokers were 48 (32.0%), Ex-Smokers 15 (10.0%), and Biomass Exposure was present in 76 (50.7%) of patients. Spirometric severity of COPD was Mild in 11 (7.3%), Moderate in 68 (45.3%), Severe in 59 (39.3%), and Very Severe in 12 (8.0%) patients. Blood Eosinophilia was present in 59 (39.3%) patients of COPD among which majority 43 (72.9%) were having Moderate 24 (40.7%) and Severe 19 (32.2%) COPD respectively.
 Conclusion: Frequency of Blood Eosinophilia in newly diagnosed COPD patients was high, among which most of the COPD patients were moderate to severe.
 doi: https://doi.org/10.12669/pjms.36.4.1624
 How to cite this:Khan GM, Zuberi FF, Bizat-uz-Zahra S, Ghafoor L. Frequency of Blood Eosinophilia in newly diagnosed Chronic Obstructive Pulmonary Disease patients. Pak J Med Sci. 2020;36(4):---------. doi: https://doi.org/10.12669/pjms.36.4.1624
 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Association between insulin resistance and BMI with FEV1 in non‐hypoxemic COPD out‐patients

“…Chronic obstructive pulmonary disease (COPD) is a group of chronic inflammatory pulmonary disorders that are characterized by partially reversible airflow obstruction which are often secondary to significant exposure to noxious gases 1 . COPD is increasingly been regarded in the context of a “cardiopulmonary continuum” 2 and is associated with a 2‐ to 3‐fold increased risk for cardiovascular diseases and type II diabetes mellitus (T2DM) and has higher frequency of blood eosinophilia in moderate to severe cases 3,4 . In a study by Mathers CD et al it was predicted that the prevalence of COPD and its resultant mortality would increase several folds by the year 2030 5 .…”

“…1 COPD is increasingly been regarded in the context of a "cardiopulmonary continuum" 2 and is associated with a 2-to 3-fold increased risk for cardiovascular diseases and type II diabetes mellitus (T2DM) and has higher frequency of blood eosinophilia in moderate to severe cases. 3,4 In a study by Mathers CD et al it was predicted that the prevalence of COPD and its resultant mortality would increase several folds by the year 2030. 5 COPD and obesity are widespread clinical conditions with significant impact on health in our society.…”

Prevalence of Gastroesophageal Reflux Disease in Asthma and Chronic Obstructive Pulmonary Disease

“…COPD is caused by GERD besides bronchogenic carcinoma, pulmonary embolism, pneumonia, and sleep dysfunction [6]. Exacerbation marks the COPD's natural history, which speeds up the worsening of lung function leading to reduced exercise (physical activities) capacity and increases the risk of mortality [7].…”